Induction of p53-mediated apoptosis in tumor cells is considered a desirable outcome of cancer therapy, whereas induction of cell-cycle arrest may interfere with drugs that target mitosis and reduce the efficacy of drugs like Paclitaxel [43]. The gene discussed is TP53; the disease is cancer.